Report cover image

Global Lidocaine Transdermal Patch Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 98 Pages
SKU # APRC20549214

Description

Summary

According to APO Research, The global Lidocaine Transdermal Patch market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Lidocaine Transdermal Patch include Teva Pharmaceutical, Tide Pharmaceutical (SINO BIOPHARM), Mylan, Teikoku, Sorrento Therapeutics, Par Pharmaceutical, Hisamitsu and Endo International, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lidocaine Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lidocaine Transdermal Patch.
The Lidocaine Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (m pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lidocaine Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Lidocaine Transdermal Patch Segment by Company

Teva Pharmaceutical
Tide Pharmaceutical (SINO BIOPHARM)
Mylan
Teikoku
Sorrento Therapeutics
Par Pharmaceutical
Hisamitsu
Endo International
Lidocaine Transdermal Patch Segment by Type

Lidocare 1.80% Transdermal Patch
Lidocare 5% Transdermal Patch
Lidocare 4% Transdermal Patch
Lidocaine Transdermal Patch Segment by Application

Clinic
Hospital Pharmacies
Online Pharmacies
Chain Pharmacies
Monomer Pharmacies
Other
Lidocaine Transdermal Patch Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lidocaine Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lidocaine Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lidocaine Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lidocaine Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Lidocaine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

98 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Lidocaine Transdermal Patch Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Lidocaine Transdermal Patch Sales Estimates and Forecasts (2020-2031)
1.3 Lidocaine Transdermal Patch Market by Type
1.3.1 Lidocare 1.80% Transdermal Patch
1.3.2 Lidocare 5% Transdermal Patch
1.3.3 Lidocare 4% Transdermal Patch
1.4 Global Lidocaine Transdermal Patch Market Size by Type
1.4.1 Global Lidocaine Transdermal Patch Market Size Overview by Type (2020-2031)
1.4.2 Global Lidocaine Transdermal Patch Historic Market Size Review by Type (2020-2025)
1.4.3 Global Lidocaine Transdermal Patch Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Lidocaine Transdermal Patch Sales Breakdown by Type (2020-2025)
1.5.2 Europe Lidocaine Transdermal Patch Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Lidocaine Transdermal Patch Sales Breakdown by Type (2020-2025)
1.5.4 South America Lidocaine Transdermal Patch Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Lidocaine Transdermal Patch Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Lidocaine Transdermal Patch Industry Trends
2.2 Lidocaine Transdermal Patch Industry Drivers
2.3 Lidocaine Transdermal Patch Industry Opportunities and Challenges
2.4 Lidocaine Transdermal Patch Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Lidocaine Transdermal Patch Revenue (2020-2025)
3.2 Global Top Players by Lidocaine Transdermal Patch Sales (2020-2025)
3.3 Global Top Players by Lidocaine Transdermal Patch Price (2020-2025)
3.4 Global Lidocaine Transdermal Patch Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Lidocaine Transdermal Patch Major Company Production Sites & Headquarters
3.6 Global Lidocaine Transdermal Patch Company, Product Type & Application
3.7 Global Lidocaine Transdermal Patch Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Lidocaine Transdermal Patch Market CR5 and HHI
3.8.2 Global Top 5 and 10 Lidocaine Transdermal Patch Players Market Share by Revenue in 2024
3.8.3 2023 Lidocaine Transdermal Patch Tier 1, Tier 2, and Tier 3
4 Lidocaine Transdermal Patch Regional Status and Outlook
4.1 Global Lidocaine Transdermal Patch Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Lidocaine Transdermal Patch Historic Market Size by Region
4.2.1 Global Lidocaine Transdermal Patch Sales in Volume by Region (2020-2025)
4.2.2 Global Lidocaine Transdermal Patch Sales in Value by Region (2020-2025)
4.2.3 Global Lidocaine Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Lidocaine Transdermal Patch Forecasted Market Size by Region
4.3.1 Global Lidocaine Transdermal Patch Sales in Volume by Region (2026-2031)
4.3.2 Global Lidocaine Transdermal Patch Sales in Value by Region (2026-2031)
4.3.3 Global Lidocaine Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Lidocaine Transdermal Patch by Application
5.1 Lidocaine Transdermal Patch Market by Application
5.1.1 Clinic
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Chain Pharmacies
5.1.5 Monomer Pharmacies
5.1.6 Other
5.2 Global Lidocaine Transdermal Patch Market Size by Application
5.2.1 Global Lidocaine Transdermal Patch Market Size Overview by Application (2020-2031)
5.2.2 Global Lidocaine Transdermal Patch Historic Market Size Review by Application (2020-2025)
5.2.3 Global Lidocaine Transdermal Patch Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Lidocaine Transdermal Patch Sales Breakdown by Application (2020-2025)
5.3.2 Europe Lidocaine Transdermal Patch Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Lidocaine Transdermal Patch Sales Breakdown by Application (2020-2025)
5.3.4 South America Lidocaine Transdermal Patch Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Lidocaine Transdermal Patch Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Teva Pharmaceutical
6.1.1 Teva Pharmaceutical Comapny Information
6.1.2 Teva Pharmaceutical Business Overview
6.1.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
6.1.5 Teva Pharmaceutical Recent Developments
6.2 Tide Pharmaceutical (SINO BIOPHARM)
6.2.1 Tide Pharmaceutical (SINO BIOPHARM) Comapny Information
6.2.2 Tide Pharmaceutical (SINO BIOPHARM) Business Overview
6.2.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolio
6.2.5 Tide Pharmaceutical (SINO BIOPHARM) Recent Developments
6.3 Mylan
6.3.1 Mylan Comapny Information
6.3.2 Mylan Business Overview
6.3.3 Mylan Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Lidocaine Transdermal Patch Product Portfolio
6.3.5 Mylan Recent Developments
6.4 Teikoku
6.4.1 Teikoku Comapny Information
6.4.2 Teikoku Business Overview
6.4.3 Teikoku Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teikoku Lidocaine Transdermal Patch Product Portfolio
6.4.5 Teikoku Recent Developments
6.5 Sorrento Therapeutics
6.5.1 Sorrento Therapeutics Comapny Information
6.5.2 Sorrento Therapeutics Business Overview
6.5.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolio
6.5.5 Sorrento Therapeutics Recent Developments
6.6 Par Pharmaceutical
6.6.1 Par Pharmaceutical Comapny Information
6.6.2 Par Pharmaceutical Business Overview
6.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
6.6.5 Par Pharmaceutical Recent Developments
6.7 Hisamitsu
6.7.1 Hisamitsu Comapny Information
6.7.2 Hisamitsu Business Overview
6.7.3 Hisamitsu Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hisamitsu Lidocaine Transdermal Patch Product Portfolio
6.7.5 Hisamitsu Recent Developments
6.8 Endo International
6.8.1 Endo International Comapny Information
6.8.2 Endo International Business Overview
6.8.3 Endo International Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Endo International Lidocaine Transdermal Patch Product Portfolio
6.8.5 Endo International Recent Developments
7 North America by Country
7.1 North America Lidocaine Transdermal Patch Sales by Country
7.1.1 North America Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Lidocaine Transdermal Patch Sales by Country (2020-2025)
7.1.3 North America Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031)
7.2 North America Lidocaine Transdermal Patch Market Size by Country
7.2.1 North America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Lidocaine Transdermal Patch Market Size by Country (2020-2025)
7.2.3 North America Lidocaine Transdermal Patch Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Lidocaine Transdermal Patch Sales by Country
8.1.1 Europe Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Lidocaine Transdermal Patch Sales by Country (2020-2025)
8.1.3 Europe Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031)
8.2 Europe Lidocaine Transdermal Patch Market Size by Country
8.2.1 Europe Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Lidocaine Transdermal Patch Market Size by Country (2020-2025)
8.2.3 Europe Lidocaine Transdermal Patch Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Lidocaine Transdermal Patch Sales by Country
9.1.1 Asia-Pacific Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Lidocaine Transdermal Patch Sales by Country (2020-2025)
9.1.3 Asia-Pacific Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Lidocaine Transdermal Patch Market Size by Country
9.2.1 Asia-Pacific Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Lidocaine Transdermal Patch Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Lidocaine Transdermal Patch Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Lidocaine Transdermal Patch Sales by Country
10.1.1 South America Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Lidocaine Transdermal Patch Sales by Country (2020-2025)
10.1.3 South America Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031)
10.2 South America Lidocaine Transdermal Patch Market Size by Country
10.2.1 South America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Lidocaine Transdermal Patch Market Size by Country (2020-2025)
10.2.3 South America Lidocaine Transdermal Patch Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Lidocaine Transdermal Patch Sales by Country
11.1.1 Middle East and Africa Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2020-2025)
11.1.3 Middle East and Africa Lidocaine Transdermal Patch Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Lidocaine Transdermal Patch Market Size by Country
11.2.1 Middle East and Africa Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Lidocaine Transdermal Patch Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Lidocaine Transdermal Patch Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Lidocaine Transdermal Patch Value Chain Analysis
12.1.1 Lidocaine Transdermal Patch Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Lidocaine Transdermal Patch Production Mode & Process
12.2 Lidocaine Transdermal Patch Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Lidocaine Transdermal Patch Distributors
12.2.3 Lidocaine Transdermal Patch Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.